- Home
- SOS vs PRTG Comparison
SOS vs PRTG Comparison
Compare SOS & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOS
- PRTG
- Stock Information
- Founded
- SOS 2004
- PRTG 1973
- Country
- SOS China
- PRTG British Virgin Islands
- Employees
- SOS N/A
- PRTG N/A
- Industry
- SOS Finance: Consumer Services
- PRTG Oil & Gas Production
- Sector
- SOS Finance
- PRTG Energy
- Exchange
- SOS Nasdaq
- PRTG Nasdaq
- Market Cap
- SOS 16.8M
- PRTG 17.7M
- IPO Year
- SOS 2017
- PRTG N/A
- Fundamental
- Price
- SOS $1.75
- PRTG $9.11
- Analyst Decision
- SOS
- PRTG
- Analyst Count
- SOS 0
- PRTG 0
- Target Price
- SOS N/A
- PRTG N/A
- AVG Volume (30 Days)
- SOS 213.6K
- PRTG 50.2K
- Earning Date
- SOS 09-23-2025
- PRTG 09-02-2025
- Dividend Yield
- SOS N/A
- PRTG N/A
- EPS Growth
- SOS N/A
- PRTG N/A
- EPS
- SOS N/A
- PRTG N/A
- Revenue
- SOS $231,424,000.00
- PRTG N/A
- Revenue This Year
- SOS N/A
- PRTG N/A
- Revenue Next Year
- SOS N/A
- PRTG N/A
- P/E Ratio
- SOS N/A
- PRTG N/A
- Revenue Growth
- SOS 150.42
- PRTG N/A
- 52 Week Low
- SOS $1.63
- PRTG $2.42
- 52 Week High
- SOS $15.51
- PRTG $23.01
- Technical
- Relative Strength Index (RSI)
- SOS 22.53
- PRTG 63.55
- Support Level
- SOS $1.65
- PRTG $7.58
- Resistance Level
- SOS $1.82
- PRTG $9.30
- Average True Range (ATR)
- SOS 0.22
- PRTG 1.03
- MACD
- SOS 0.04
- PRTG 0.03
- Stochastic Oscillator
- SOS 10.53
- PRTG 73.85
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.